160TiP A phase I/II study of CFT1946, a novel BIDAC degrader targeting mutant BRAF V600 solid tumors including metastatic colorectal cancer (CRC) in combination with cetuximab
作者
María Vieito,M. McKean,A. Spira,Ezra Y. Rosen,Jordi Ahnert Rodon,Víctor Moreno,Valentina Gambardella,Omar Saavedra Santa Gadea,Sophie Cousin,Philippe Alexandre Cassier,Iphigénie Korakis,B.A. Van Tine,J.S. Wang,V.T-L. Ma,M.E. Elez Fernandez,M. Pelster,E. Hinojosa,Riadh Lobbardi,Eunju Hurh,Elizabeth Iannotti Buchbinder